Apple Reiterated at Outperform and 4 Reiterated Ratings Not to Miss
December 21, 2012
Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on December 21st.
TIBCO Software (NASDAQ:TIBX): UBS reiterated its rating of Buy for this company and changed its price target from $32 to $30.
MasterCard (NYSE:MA): Argus reiterated its rating of Buy for this company and changed its price target from $525 to $575.
Our 20-page proprietary analysis of Apple’s stock is ready. Click here to get your Cheat Sheet report now.
Insulet (NASDAQ:PODD): Canaccord Genuity reiterated its rating of Buy for this company and changed its price target from $24.5 to $29.
Apple (NASDAQ:AAPL): RBC Capital Mkts reiterated its rating of Outperform for this company and changed its price target from $750 to $725.
Endocyte (NASDAQ:ECYT): RBC Capital Mkts reiterated its rating of Outperform for this company and changed its price target from $12 to $15.
Don’t Miss: Apple Won’t Back Down.
Premium Newsletters
Gold & Silver
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More
Commodities Premium
There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more
ETF Investing
At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more
Wall St. Cheat Sheet has been featured in these fine media outlets:
